TARRYTOWN, N.Y., Oct. 24, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that Science magazine has ranked Regeneron as the #1 employer in the global biopharmaceutical industry in the journal's annual Top Employers Survey for the second year in a row. This distinction will be celebrated Monday, October 28, in conjunction with a groundbreaking ceremony for two new buildings to be constructed at the Regeneron campus in Westchester County, New York.
U.S. Senator Charles E. Schumer, U.S. Rep. Nita Lowey, Empire State Development Corp. President & CEO Kenneth Adams, and other public officials are scheduled to participate in an event with Regeneron employees that will celebrate the biotechnology company's latest expansion and the emergence of the lower Hudson Valley as a life sciences cluster.
"Regeneron's tremendous growth and our current expansion plans are undoubtedly thanks to our employees. If we are the best place to work, it is because we have the best employees and a culture where they feel empowered and challenged," said Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron. George D. Yancopoulos, Chief Scientific Officer and President, Regeneron Laboratories, said, "As we are a company founded on scientific excellence, it is very meaningful to us to be recognized by Science magazine two consecutive years now as the top place to work in the industry."
The new facilities, for which site preparation is underway, will include a total of 300,000 square feet of laboratory and office space, with a projected move-in date of third quarter 2015. The expansion will increase Regeneron's square footage on the campus by more than 40 percent and make it possible for Regeneron to create approximately 400 new full-time jobs in Westchester, where it currently employs more than 1,500. With a total of over 2,200 employees, including nearly 700 in the Regeneron Industrial Operations and Product Supply group in Rensselaer, New York near Albany, Regeneron is the largest biotechnology company in New York
State and one of the five largest in the world by market capitalization.
The 2013 Science survey sought to identify the companies with the best reputations as employers, based on 3,656 survey responses from readers of Science and other survey invitees. Survey participants came from North America (81%), Europe (10%), and Asia/Pacific Rim (7%); over 80% worked in private industry. Details of the rankings and survey results can be found in sciencecareers.org and will be featured in the October 25, 2013 print issue.
About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. For additional information about the company, please visit www.regeneron.com.
SOURCE Regeneron Pharmaceuticals, Inc.
